2009 Recommendations First-Line Chemotherapy
{"Image DocumentName": "2009 Recommendations First-Line Chemotherapy", "Image ImageDescription": "Recommendation A9. Based on the results of one large phase III randomized controlled trial, clinicians may consider the addition of cetuximab to cisplatin-vinorelbine in first-line therapy in patients with an EGFR positive tumor as measured by immunohistochemistry. Cetuximab may be continued, as tolerated, until disease progression. Stage IV NSCLC slide set.  \u00a9American Society of Clinical Oncology All rights reserved.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}